Mood Peptides
Peptides discussed for anxiolytic or mood-modulating properties.
DSIP
Low EvidenceA neuropeptide studied for its role in sleep regulation and stress modulation.
Orforglipron
High EvidenceThe first oral non-peptide GLP-1 receptor agonist, FDA-approved in April 2026 for chronic weight management with no food or water restrictions.
Oxytocin
High EvidenceA neuropeptide involved in social bonding, mood regulation, and reproductive functions.
Selank
Medium EvidenceA synthetic peptide analog of tuftsin studied for anxiolytic and nootropic properties.
Semaglutide
High EvidenceA GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management.
Semax
Medium EvidenceA synthetic peptide derived from ACTH, studied for cognitive enhancement and neuroprotective effects.
Track Your Research with PepTracker Pro
Try the Free App →